I thought they would also target the skin preparation prior to surgery ......... or is the problem that 1801 is not an antiseptic, and will only target certain bugs leaving all the others to flourish.
I'm guessing the other route of trying to get the 1801 directly to the wound or in the blood was not going to be effective or might have been more risky than a nasal spray.
Good to see they are de-risking the company, I wonder what is next
Ann: Antimicrobial Platform Update and Launch of BTX 1801 Study, page-29
-
- There are more pages in this discussion • 50 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
0.020(6.25%) |
Mkt cap ! $627.0M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 34.8¢ | 33.5¢ | $1.557M | 4.593M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 731915 | 33.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 433853 | 10 |
View Market Depth
| Last trade - 11.10am 14/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |